In the present study we found that patients with ACLF based on ALD and NAFLD showed increased plasma SOD with disease progression (14 days after hospital admission), while ACLF patients due to CHB infection tend to recover with a decreased SOD level. This evidence concerns the gene SOD1 and metabolic dysfunction-associated steatotic liver disease.